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gastrointestinal tract ( 9, 10 ). Studies comparing ileal tis-
sue from germ-free (GF) and  Bacteroidetes thetaiotaomicron-
 colonized mice have shown that microbial colonization 
modifi es the expression of genes involved in the metabo-
lism of xenobiotics (foreign compounds) as well as in host 
nutrient (amino acids, lipids, vitamins, and ions) absorp-
tion and processing ( 6 ). 
 Evidence is now accumulating to indicate that perturba-
tions of gut microbiota composition/functions may play 
an important role in the development of diseases associ-
ated with altered metabolism ( 11, 12 ). The diversity of the 
gut microbiota in both mice and humans is low on the 
phylum level, where the majority of species (>95%) belong 
to Firmicutes and Bacteroidetes ( 1, 2, 13 ). In contrast, the 
microbial diversity on species levels is very high ( 1, 2, 13 ). 
Recent studies in both mice and humans demonstrated 
that obesity is associated with an altered gut microbial 
ecology, exemplifi ed by lower microbial diversity and de-
creased levels of Bacteroidetes ( 2, 3, 13, 14 ). The shift in 
microbial composition is associated with alterations in the 
gut microbial metagenome, notably an enrichment of 
genes involved in energy harvest ( 15 ). Furthermore, GF 
mice have decreased adiposity and hepatic triglyceride lev-
els compared with conventionally raised (CONV-R) mice 
and are resistant to diet-induced obesity ( 16, 17 ). Although 
the mechanisms through which the gut microbiota pro-
motes obesity have not been clarifi ed in detail, it is known 
 Abstract  The gut microbiota has recently been identifi ed 
as an environmental factor that may promote metabolic dis-
eases. To investigate the effect of gut microbiota on host 
energy and lipid metabolism, we compared the serum me-
tabolome and the lipidomes of serum, adipose tissue, and 
liver of conventionally raised (CONV-R) and germ-free 
mice. The serum metabolome of CONV-R mice was charac-
terized by increased levels of energy metabolites, e.g., pyru-
vic acid, citric acid, fumaric acid, and malic acid, while 
levels of cholesterol and fatty acids were reduced. We also 
showed that the microbiota modifi ed a number of lipid spe-
cies in the serum, adipose tissue, and liver, with its greatest 
effect on triglyceride and phosphatidylcholine species. Tri-
glyceride levels were lower in serum but higher in adipose 
tissue and liver of CONV-R mice, consistent with increased 
lipid clearance.  Our fi ndings show that the gut microbiota 
affects both host energy and lipid metabolism and high-
lights its role in the development of metabolic diseases. —
Velagapudi, V.R., R. Hezaveh, C. S. Reigstad, P. Gopalacharyulu, 
L. Yetukuri, S. Islam, J. Felin, R. Perkins, J. Borén, M. Orešič, 
and F. Bäckhed.  The gut microbiota modulates host energy 
and lipid metabolism in mice.  J. Lipid Res . 2010. 51: 
1101–1112 . 
 Supplementary key words metabolomics • lipidomics 
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was dried under constant fl ow of nitrogen. Twenty-fi ve microli-
ters of 2% methoxyamine hydrochloride in pyridine was added 
to the dried sample and incubated at 45°C for 1 h and then de-
rivatized with 25 µl of  N -methyl- N -(trimethylsilyl)-trifl uoroacet-
amide by incubating at 45°C for 1 h. Five microliters of retention 
index standard mixture with fi ve alkanes (400 mg/l) was added 
to the metabolite mixture. Sample order for analysis was estab-
lished by randomization. The samples were analyzed on a Leco 
Pegasus 4D GC coupled to time-of-fl ight MS (GCxGC-ToF/MS) 
mass spectrometer with Agilent technologies 6890N GC and 
Combi PAL autosampler. 
 The metabolites were identifi ed using an in-house reference 
compound library and by searching the reference mass spectral 
library. Mass spectra from the GCxGC-TOF/MS analysis were 
searched against the Palisade Complete Mass Spectral Library, 
600K Edition (Palisade Mass Spectrometry, Ithaca, NY), which 
includes all spectra available from the NIST 2002 and Wiley reg-
istry collections and 150,000 other spectra. The matches to refer-
ence spectra are based on a weighted dot product of the two 
spectra, with higher  m/z peaks having more weight than the 
lower. A similarity value is assigned between 0 and 999, with 999 
being a perfect match and 750 generally considered as a reason-
able match. We used the conservative cutoff criterion of 850 for 
identifi cation. 
 Lipidomic analyses using ultra performance liquid 
chromatography/MS platform 
 Serum (10 µl) and liver samples (5–10 mg) were diluted with 
0.9% NaCl (10 µl for serum, 50 µl for liver) and adipose tissue 
samples (5–10 mg) were diluted with 200 µl PBS buffer. All sam-
ples were spiked with an internal standard (10 µl for serum and 
liver, 20 µl for adipose) ( 24 ). The samples were subsequently ex-
tracted with chloroform-methanol (2:1) solvent (100 µl for se-
rum, 200 µl for liver, 400 µl with 40 µl of PBS buffer for adipose), 
homogenized with a glass rod (serum) or a Retsch homogenizer 
(Mixer MILL type MM301) for 2 min at 25 Hz (liver) or 20 Hz 
(adipose) at 4°C by adding two zirconium oxide grinding balls, 
vortexed (1 min for serum, 2 min for liver and adipose), incu-
bated at room temperature (1 h for serum and adipose, 30 min 
for liver), and centrifuged at 5,590  g for 3 min. From the sepa-
rated lower phase, an aliquot (60 µl for serum, 100 µl for liver, 
200 µl for adipose) was mixed with a labeled standard mixture 
(three stable isotope-labeled reference compounds; 10   l for se-
rum and liver, 20 µl for adipose) and 0.5–1.0   l injection was 
used for LC/MS analysis. Sample order for analysis was estab-
lished by randomization. Lipid extracts were analyzed on a Q-ToF 
Premier mass spectrometer (Waters) combined with an Acquity 
ultra performance liquid chromatography/MS (for specifi c set-
tings, see Supplementary Methods). 
 Modeling 
 To include the correlation structure of lipidomics data into 
the analysis and therefore explore possible associations between 
different lipid molecular species, we applied the partial least 
squares discriminant analysis (PLS/DA) ( 25, 26 ) using the SIM-
PLS algorithm to calculate the model ( 27 ). PLS/DA is a common 
approach to multivariate metabolomics data analysis ( 28, 29 ). 
PLS/DA analysis maximizes the product of variance matrix of 
measured variables (e.g ., lipidomic profi le data) and correlation 
of measured data with properties of interest (e.g., CONV-R vs. GF 
mice). PLS/DA makes latent variables of original matrix  X (pre-
dictor variable, e.g., lipidomics data) and matrix  Y (response vari-
able; e.g., mouse groups). Latent variables are formed as a linear 
combination of all the original variables in  X in such a way that 
most of the association with Y variables can be explained together 
that GF mice have increased fatty acid oxidation and de-
creased lipogenesis ( 16, 17 ). 
 Novel approaches are now emerging to measure and 
model metabolism. A powerful approach to understand 
host metabolism is to produce multivariate phenotypic sig-
natures such as metabolite profi les (metabolomics). Me-
tabolomics of plasma from GF and CONV-R mice have 
begun to reveal a profound microbial effect of host me-
tabolism, especially on amino acid metabolites ( 18, 19 ). 
For example, the gut microbiota is required for the pro-
duction of bioactive indole-containing metabolites, such 
as the antioxidant indole-3-propionic acid, from trypto-
phan ( 19 ). Despite our increased understanding of how 
microbes affect the host metabolome ( 8, 18–22 ), our 
knowledge of microbial modulation of host energy and 
lipid metabolism is limited. In particular, it is not clear 
how the gut microbiota affects the systemic lipid metabo-
lism in metabolically important organs such as adipose tis-
sue and liver. Given the complexity of systemic lipid 
metabolism ( 23 ), it is clear that a multi-tissue approach is 
needed to clarify these issues. 
 Here, we use MS-based metabolomics of serum in com-
bination with MS-based lipidomics of serum, white adipose 
tissue, and liver of GF and CONV-R mice to delineate how 
the gut microbiota affects the host’s energy and lipid me-
tabolism. We show that the presence of a gut microbiota is 
refl ected by increased levels of pyruvic acid and tricarbox-
ylic acid metabolites in serum. Furthermore, we observed 
altered lipid metabolism in serum, white adipose tissue, 
and liver, with the most notable effects on triglyceride and 
phosphatidylcholine species. 
 MATERIALS AND METHODS 
 Animals 
 Male GF Swiss Webster mice (aged 12–14 weeks) were main-
tained in fl exible plastic fi lm isolators under a strict 12-h-light 
cycle (lights on at 06:00 h ). Sterility was routinely confi rmed by 
culturing and PCR analysis from feces using universal primers 
amplifying the 16S rRNA gene. Age-matched male CONV-R Swiss 
Webster mice were transferred to identical isolators at weaning. 
Both groups of mice were fed an autoclaved chow diet (Labdiet, 
St. Louis, MO) ad libitum unless otherwise stated. To produce 
conventionalized (CONV-D) mice, we conventionalized 12-week-
old GF mice with gut microbiota from Swiss Webster donor mice 
as previously described ( 16 ). The study protocols were approved 
by the University of Gothenburg Animal Studies Committee. 
 Blood was collected from the vena cava under deep isofl urane 
anesthesia after a 4 h fast, unless otherwise stated, and the mice 
were subsequently euthanized by cervical dislocation. The liver 
and epididymal white adipose tissues were immediately removed 
and snap frozen in liquid nitrogen. 
 Metabolomic analyses using GC coupled to time-of-fl ight 
MS platform 
 Serum samples (30 µl) were combined with 10 µl of an inter-
nal standard, labeled palmitic acid (16:0-16,16,16d 3 ; 500 mg/l), 
and 400 µl of methanol, vortexed for 2 min, and incubated for 30 
min at room temperature. The supernatant was separated by cen-
trifugation at 5,590  g for 5 min at room temperature. The sample 
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a 4 h fast by using two-dimensional GC coupled to time-
of-fl ight MS (GCxGC-ToF/MS) and identifi ed 185 metab-
olites. Modeling and clustering by PLS/DA revealed 
that serum metabolite profiles clustered according 
to colonization status ( Fig. 1A , corresponding VIP 
values are listed in supplementary Table I, and all 29 
metabolites that are significantly altered in CONV-R 
compared with GF mice are listed in supplementary 
Table II). 
 As expected, we observed increased levels of the micro-
bially derived metabolites and metabolites involved in 
xenobiotic metabolism in serum from CONV-R mice ( Fig. 
1B ). 3-Hydroxyphenylpropionic acid, a product of cate-
chin metabolism ( 33 ), and hydrocinnamic acid (or ben-
zenepropanoic acid), which is produced by clostridium 
species ( 34 ), were elevated in CONV-R mice. In addition, 
we observed increases in rhamnose, a component of the 
outer cell membrane of acid-fast bacteria in the mycobac-
terium genus ( 35 ) ( Fig. 1B ). These fi ndings demonstrate 
that the host serum metabolite profi le refl ects microbial 
metabolism in the intestine. Serum levels of glucuronic 
acid, which is associated with phase II (conjugation) 
metabolism of xenobiotic compounds ( 36 ), were also 
increased in CONV-R mice compared with CONV-R mice 
( Fig. 1B ). This increase is consistent with increased ex -
pression of  Ugt2b38 in the liver (R. Hezaveh, C. Reigstad, 
P. Gopalacharyulu, M. Oresic, F. Bäckhed, unpublished 
data). 
 The gut microbiota also promoted increases in the 
serum levels of pyruvic acid and the tricarboxylic acid 
metabolites citric acid, fumaric acid, and mails acid (all 
metabolites involved in energy metabolism) and reduced 
serum levels of urea and the urea cycle metabolite 
 L -ornithine ( Fig. 1B ). Serum levels of several essential cel-
lular building blocks, including sugars, amino acids, and 
fatty acids, were also modifi ed. In particular, serum from 
CONV-R mice had decreased levels of long-chain fatty 
acids [the saturated fatty acid palmitic acid (16:0) and 
the unsaturated essential fatty acid linoleic acid (18:2n-6)] 
and cholesterol, and increased levels of the dietary 
phytosterol campesterol and glucose ( Fig. 1B ). We also 
identifi ed increased serum levels of the monoamine 
ne urotransmitters dopamine and tyramine and of  trans -
2-aminomethylcyclopropanecarboxylic acid, a cyclopro-
pane analog of   -aminobutyric acid, in CONV-R mice 
( Fig. 1B ). 
 The gut microbiota affects the serum lipidome 
 To investigate in further detail how the gut microbiota 
affects the serum lipidome, we performed high-resolution 
lipidomics of serum from CONV-R and GF mice after a 
4 h fast using ultra performance liquid chromatography/
MS. This technology allows several hundred lipid species 
to be simultaneously and accurately analyzed ( 24 ). We 
identifi ed and quantifi ed 333 lipids in serum from CONV-R 
and GF mice, and PLS/DA modeling and clustering re-
vealed signifi cant differences in the global serum lipid 
profi les between CONV-R and GF mice ( Fig. 2A ; corre-
sponding VIP values are listed in supplementary Table III, 
with the variation in  X . Contiguous-blocks cross-validation 
method and  Q 2 scores were used to develop the models ( 30 ).  Q 2 
indicates how accurately the data, either classed or nonclassed, 
can be predicted, and this term is more relevant to supervised 
pattern recognition processes.  Q 2 scores over 0.08 indicate a 
model that is better than chance, whereas a score between 0.7 
and 1.0 demonstrates a highly robust trend. For each model 
built, the loading scores and the variable importance on projec-
tion (VIP) parameters were examined, in conjunction with the 
original data, to identify which metabolites contributed most to 
clusterings or a trend observed in the data. Loading scores de-
scribe the correlation between the original variables and the new 
component variables, whereas VIP parameters are essentially a 
measure of the degree to which a particular variable explains the 
 Y variance (class membership). PLS/DA analyses were performed 
using Matlab, version 7.5 (Mathworks, Natick, MA) and PLS 
Toolbox, version 4.2, of the Matlab package (Eigenvector Re-
search, Wenatchee, WA). 
 Measurements of serum lipids 
 Total serum triglycerides and cholesterol were analyzed ac-
cording to the manufacturer’s protocols (Thermo Electron, 
Grenoble, France). The lipid distribution in plasma lipoprotein 
fractions was assessed by fast protein liquid chromatography gel 
fi ltration with a Superose 6 HR 10/30 column (Pharmacia, Upp-
sala, Sweden). Each fraction was subsequently analyzed for tri-
glyceride or cholesterol content as above. Plasma lipoproteins 
were also separated by agarose gel electrophoresis ( 31 ) and the 
chylomicron staining was quantifi ed by densitometry. 
 Hepatic VLDL production 
 To determine the VLDL production rate, lipolysis was blocked 
by injecting mice with 12.5 mg of Triton WR1339 (10% solution 
in saline) intravenously after an overnight fast. Blood samples 
were drawn from the tail vein at 0, 10, 30, 60, and 90 min after 
injection. Triglycerides were measured using an enzymatic color-
imetric assay (Thermo Electron, Grenoble, France) according to 
the manufacturer’s protocol. 
 Administration of lipid bolus 
 Mice were gavaged with 400 µl heavy whipping cream (36% 
fat, Arla, Sweden) after an overnight fast and euthanized 1 or 4 h 
after the lipid bolus. Serum was collected and triglycerides were 
measured as above. 
 Statistics 
 Student’s  t -test was applied to test for pairwise differences be-
tween the means, single factor ANOVA was applied to test for 
differences among means, and Dunn-Sidák multiple comparison 
procedure was applied to identify which means were signifi cantly 
different, using the  multcompare function of the MATLAB Statisti-
cal Toolbox.  P values < 0.05 were considered as statistically signifi -
cant. False Discovery Rate or the expected proportion of false 
discoveries among the rejected hypotheses was estimated using 
the method by Benjamini et al . ( 32 ). The adjusted  P values ( q -
values) were calculated with the function “p.adjust” using the R 
statistical software (http://www.r-project.org/). 
 RESULTS 
 The gut microbiota affects the serum metabolome 
 We performed MS-based metabolic profiling of 
serum from CONV-R and GF Swiss Webster mice after 
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cluding two of the fi ve most abundant) were reduced ( Fig. 
2D, E ; supplementary Table IV). 
 To investigate whether a shorter microbial colonization 
could induce similar changes in the serum lipidome, we 
colonized 12-week-old GF mice for 2 weeks (CONV-D) 
and analyzed their serum lipids on the same platform as 
above. We found that the reductions in triglyceride levels 
in CONV-D mice compared with GF counterparts were 
similar to those observed in CONV-R mice (supplemen-
tary Table IV). In contrast, CONV-D mice did not exhibit 
and all signifi cantly altered lipid species are listed in sup-
plementary Table IV). 
 We found that CONV-R mice had elevated serum levels 
of two cholesteryl ester and three sphinghomyelin species 
( Fig. 2B, C ; supplementary Table IV). A more dramatic 
effect of the gut microbiota was observed for phosphatidyl-
cholines and triglycerides: serum levels of 18 phosphati-
dylcholine species (including three of the most abundant) 
were increased in CONV-R mice while three species were 
reduced; and serum levels of nine triglyceride species (in-
Fig. 1. Serum metabolite profi les in CONV-R compared with GF mice. A: PLS/DA of serum metabolites 
from GF (n = 5) and CONV-R (n = 5) mice after a 4 h fast. Scores for latent variable LV1 and sample are 
depicted. Regression coeffi cients and VIP scores for the top ranked metabolites are listed in supplementary 
Table I. B: Selected serum metabolites that are signifi cantly different in CONV-R (n = 5) compared with GF 
(n = 5) mice. For a complete list of microbially altered serum metabolites, see supplementary Table II. Data 
are expressed as mean values ± SEM. * P < 0.05; ** P < 0.01; and *** P < 0.001 compared with GF mice.
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The gut microbiota and lipidome alterations 1105
mice as above. PLS/DA modeling and clustering revealed 
signifi cant differences in the global adipose lipid profi les 
between CONV-R and GF mice after a 4 h fast ( Fig. 3A ; 
corresponding VIP values are listed in supplementary Ta-
ble V and signifi cantly altered lipid species are listed in 
supplementary Table VI). 
 In contrast to the differences observed in the serum lipi-
dome, the only signifi cant change in the phosphatidylcho-
line species was a decrease in one of the most abundant 
species in adipose tissue from CONV-R mice ( Fig. 3B ) and 
increased serum levels of cholesteryl esters, sphingomy-
elins, or phosphatidylcholines (supplementary Table IV). 
In fact, two of the three reduced phosphatidylcholines in 
CONV-R mice were also reduced in CONV-D mice (sup-
plementary Table IV). 
 The gut microbiota affects the adipose lipidome 
 We also explored the effect of the gut microbiota on the 
adipose lipidome by analyzing epididymal adipose tissue 
using the same high-resolution lipidomics technique and 
Fig. 2. Serum lipidomic profi les in CONV-R compared with GF mice. A: PLS/DA of serum lipids from GF 
(n = 8) and CONV-R (n = 5) mice after a 4 h fast. Scores for latent variable LV1 and sample are depicted. 
Regression coeffi cients and VIP scores for the top ranked lipids are listed in supplementary Table III. B-E: 
Absolute concentrations of the most abundant cholesteryl esters (ChoE), sphingomyelins (SM), phosphati-
dylcholines (PC), and triglycerides (TG) in serum from GF and CONV-R mice. For a complete list of micro-
bially altered serum lipids, see supplementary Table IV. Data are expressed as mean values ± SEM. * P < 0.05; 
** P < 0.01; and *** P < 0.001 compared with GF mice.
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creased triglyceride levels correlated with increased adi-
pose mass and elevated levels of leptin (10.4 ± 1.9 vs. 22.0 ± 
1.3 ng/ml,  P = 0.003, n = 4/group) and insulin (1.3 ± 0.3 
vs. 3.8 ± 0.9 ng/ml,  P = 0.03, n = 4/group) in CONV-R 
mice compared with GF counterparts, which is agreement 
with a previous study ( 16 ). 
 The gut microbiota affects the liver lipidome 
 We next used the same high-resolution lipidomics 
technique and mice as above to analyze the effect of the 
gut microbiota on the liver lipidome. PLS/DA model-
ing and clustering revealed signifi cant differences in 
the global liver lipid profi les between CONV-R and GF 
mice after a 4 h fast ( Fig. 4A , corresponding VIP values 
are listed in supplementary Table VII and signifi cantly 
altered lipid species are listed in supplementary Table 
SVIII). 
 We observed many more microbiota-related changes in 
the liver lipidome compared with the serum and adipose 
tissue (supplementary Table VIII). In contrast to the se-
rum lipidome, we observed decreased levels of two of the 
three most abundant cholesteryl ester species in CONV-R 
mice ( Fig. 4B ). We also observed increases in four of the 
shorter phosphatidylcholines (  36C) and decreases in 
the longer (  38C) phosphatidylcholines in CONV-R mice 
(supplementary Table VIII). Furthermore, 95 triglyceride 
species (including four of the most abundant) increased 
in CONV-R mice and only two decreased ( Fig. 4C ; supple-
mentary Table VIII). 
 In contrast to serum triglycerides, the liver triglycer-
ides only trended toward being increased in CONV-D 
mice following a 2 week colonization of GF mice (sup-
plementary Table VIII), suggesting that liver triglycer-
ides responded slower than serum triglycerides to 
colonization. 
 Levels of chylomicrons but not VLDL are reduced in 
serum of CONV-R mice 
 Triglycerides in serum exist mainly packaged in the 
form of lipoproteins: chylomicrons, which transport di-
etary triglycerides from the intestine, and VLDL, which 
transport hepatic triglycerides from the liver to adipose tis-
sue ( 37 ). We therefore investigated if a specifi c effect of 
the gut microbiota on serum chylomicron levels could ex-
plain why we observed reductions in triglyceride species in 
serum but increases in triglyceride species in adipose tis-
sue and liver from CONV-R mice. 
 Agarose gel electrophoresis followed by lipid staining of 
the chylomicron region of agarose gels demonstrated 40% 
lower chylomicron levels in CONV-R mice compared with 
GF mice ( Fig. 5A, B ). In contrast, fast protein liquid chro-
matography followed by enzymatic measurements of tri-
glyceride content in each fraction showed that there were 
no differences in VLDL-triglyceride levels between CONV-R 
and GF mice ( Fig. 5C ). By using Triton WR1339 to inhibit 
peripheral clearance of lipoproteins, mainly VLDL after 
an overnight fast, we also showed that the VLDL produc-
tion rate was higher in CONV-R mice compared with GF 
mice ( Fig. 5E, F ). 
there were no alterations in the cholesteryl ester and 
sphingomyelin species (data not shown). Of all the lipid 
species measured in the adipose tissue, the gut microbiota 
had its greatest effect on the triglycerides: in further con-
trast to the serum lipidome, adipose levels of 13 triglycer-
ide species (including one of the most abundant) were 
increased in CONV-R mice and only two were reduced 
( Fig. 3C ; supplementary Table VI). As expected the in-
Fig. 3. Lipidomic profi les of epidiymal adipose tissue in CONV-R 
compared with GF mice. A: PLS/DA of adipose lipids from GF (n = 
9) and CONV-R (n = 5) mice after a 4 h fast. Scores for latent vari-
able LV1 and sample are depicted. Regression coeffi cients and VIP 
scores for the top ranked lipids are listed in supplementary Table 
V. B–C: Absolute concentrations of the most abundant phosphati-
dylcholines (PC) and triglycerides (TG) in adipose tissue from GF 
and CONV-R mice. For a complete list of microbially altered adi-
pose lipids, see supplementary Table VI. Data are expressed as 
mean values ± SEM. * P < 0.05 compared with GF mice.
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fractions obtained in  Fig. 2B suggested that CONV-R mice 
have slightly elevated LDL cholesterol, while HDL choles-
terol was unaltered ( Fig. 5D ). 
 Triglyceride absorption from the gut is not reduced in 
CONV-R mice 
 The reduced levels of chylomicrons observed in CONV-R 
mice after a 4 h fast could be caused by decreased triglyc-
eride absorption from the gut and/or increased triglyc-
eride clearance. To directly test the fi rst possibility, we 
administered a bolus of heavy whipping cream (36% tri-
glycerides) intragastrically to CONV-R and GF mice after 
an overnight fast. We did not fi nd any signifi cant differ-
ences in serum triglycerides at baseline or after lipid bolus 
administration ( Fig. 6A ). However, analysis of agarose gels 
showed that chylomicron levels in serum from CONV-R 
mice were reduced 4 h after the lipid bolus, but not after 1 
h ( Fig. 6B ). Together, these results are consistent with in-
creased triglyceride clearance but not with decreased tri-
glyceride absorption from the gut in the presence of gut 
microbiota. 
 In addition, we performed lipidomics at 1 and 4 h after 
the lipid bolus to investigate whether the gut microbiota 
affected the absorption/metabolism of specifi c lipid spe-
cies under these conditions. We observed increases in two 
of the fi ve most abundant phosphatidylcholines in CONV-R 
mice serum 1 h and 4 h after a lipid bolus and decreases 
in phosphatidylcholine (36:2) in CONV-R mice serum 1 h 
after a lipid bolus (supplementary Figs. IB and IIB). The 
levels of three of the fi ve most abundant sphingomyelins 
in serum after 4 h and one sphingomyelin after 1 h were 
elevated in CONV-R mice, and sphingomyelins (d18:1/
22:0) were reduced in CONV-R mice serum both 1 h and 
4 h after a lipid bolus (supplementary Fig. IB and IIB). All 
signifi cantly altered lipid species are listed in supplemen-
tary Tables IX and X. Our data thus suggest that the gut 
microbiota does not affect triglyceride absorption; how-
ever, other lipid species are modulated by a gut microbiota 
following lipid administration. 
 DISCUSSION 
 In this study, we investigated how the gut microbiota af-
fects host energy and lipid metabolism by comparing se-
rum, white adipose tissue, and liver from CONV-R and GF 
mice. Analysis of the serum metabolome showed that en-
ergy metabolites were increased in CONV-R mice. In addi-
tion, we demonstrated that the microbiota modifi ed a 
number of lipid classes in the serum, adipose tissue, and 
liver, with its most dramatic effect on triglyceride and 
phosphatidylcholine species. Our study further supports 
the emerging view that the gut microbiota plays a role in 
modulating host metabolism. 
 Our observation of increased levels of pyruvic acid and 
tricarboxylic acid metabolites in serum from CONV-R 
mice is consistent with higher energy metabolism in the 
presence of gut microbiota ( 38 ). In agreement with these 
fi ndings, we also observed upregulation of genes involved 
 Because our serum lipidomics data ( Fig. 2B ) indicated 
that CONV-R mice had elevated cholesteryl esters, we in-
vestigated whether the gut microbiota affected HDL and/
or LDL cholesterol. Determining cholesterol levels in the 
Fig. 4. Lipidomic profi les of liver tissue in CONV-R compared 
with GF mice. A: PLS/DA of liver lipids from GF (n = 9) and 
CONV-R (n = 5) mice after a 4 h fast. Scores for latent variable 
LV1 and sample are depicted. Regression coeffi cients and VIP 
scores for the top ranked lipids are listed in supplementary Ta-
ble VII. B–C: Absolute concentrations of the most abundant cho-
lesteryl esters (ChoE) and triglycerides (TG) in liver tissue from 
GF and CONV-R mice. For a complete list of microbially altered 
liver lipids, see supplementary Table VIII. Data are expressed as 
mean values ± SEM. * P < 0.05; ** P < 0.01 compared with GF 
mice.
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study of obese and lean twins showed that the gut micro-
biome (collection of all microbial genes) of obese indi-
viduals is associated with an enrichment in carbohydrate 
and lipid utilizing genes ( 13 ). Thus, rapid processing of 
in the tricarboxylic acid cycle and pyruvate metabolism in 
the liver transcriptome of CONV-R versus GF mice (R. 
Hezaveh, C. Reigstad, P. Gopalacharyulu, M. Oresic, and 
F. Bäckhed, unpublished data). Furthermore, a recent 
Fig. 5. Serum lipoprotein profi les in CONV-R compared with GF mice. A: Representative agarose gel of 
the serum samples from GF (n = 4) and CONV-R (n = 5) mice where chylomicrons are at the origin, VLDLs 
in the pre band, LDL in the  band, and HDL in the  band. B: Quantifi cation of the agarose gels in (A). 
C: Total triglycerides measured in gel chromatography fractions of pooled serum (n = 5 per group) from GF 
and CONV-R mice after a 4 h fast. Fractions containing VLDL are indicated. D: Total cholesterol measured 
in the same gel chromatography fractions as in C. Fractions containing LDL and HDL are indicated. E: Tri-
glycerides in serum from GF (n = 6) and CONV-R (n = 5) mice after an overnight fast and administration of 
Triton WR 1339. F: VLDL production rates based on data in E. Data are expressed as mean values ± SEM. * 
P < 0.05 compared with GF mice.
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changes in any other lipid species. Interestingly, the in-
creased triglyceride species in adipose tissue from CONV-R 
mice contained even-numbered fatty acids, indicating that 
they are derived from de novo lipogenesis (C16), elonga-
tion (C18), and desaturation (18:1) ( 39 ). In contrast, the 
two decreased species contained 45 and 53 carbons, re-
spectively, suggesting that they may be derived from the 
diet. We noted the most extensive microbially induced al-
terations of triglycerides in the liver, which potentially can 
be explained by increased substrate infl ux in the form of 
short-chain fatty acids from the colon ( 40 ) and increased 
glucose and insulin levels ( 16 ). Although we did not di-
rectly attempt to address whether microbial colonization 
energy metabolites in the liver and other peripheral or-
gans may refl ect increased energy availability. 
 We showed that the microbiota had a dramatic effect on 
triglyceride species, with reductions in the levels of nine 
species in serum and increases in 13 species in adipose tis-
sue and 95 species in liver from CONV-R mice compared 
with GF mice after a 4 h fast. Previous studies have shown 
reduced triglyceride serum levels and increased liver tri-
glyceride levels and adiposity in the presence of a gut mi-
crobiota ( 16, 17 ), but this is the fi rst study to highlight the 
dramatic changes in a large number of individual triglyc-
eride species. We also demonstrated that the increased 
adiposity results from increased triglycerides and not from 
Fig. 6. Postprandial lipid uptake in CONV-R and 
GF mice. A: Serum triglyceride levels in GF (n = 7–8/
time point) and CONV-R (n = 6/time point) before 
and 1 and 4 h after an intragastric cream (36% fat) 
bolus. B: Levels of chylomicron remnant levels in the 
same serum as in A analyzed by agarose gel electro-
phoresis. * P < 0.05 compared with GF mice.
 Fig.  7. Summary of the microbiota-induced changes in energy and lipid metabolism identifi ed in our 
study. Energy metabolites are increased in the serum and are refl ected by an upregulation of related genes 
in the liver transcriptome. Triglyceride (TG) levels are decreased in the serum and increased in adipose tis-
sue and the liver of CONV-R mice after a 4 h fast. The serum reduction in TG is caused by a decrease in 
chylomicrons (CM). Lipid absorption is not reduced in CONV-R mice, and we propose that lipid clearance is 
increased. In agreement, we have previously shown that a microbiota increases suppression of angiopoietin-
like protein 4/fasting-induced adipose factor (Angptl4/Fiaf) ( 16 ), an inhibitor of LPL, which will promote 
increased lipid clearance. VLDL production in the liver is increased in CONV-R mice, which may explain 
why VLDL-TG serum levels are not reduced in CONV-R mice despite increased clearance. Furthermore, 
phosphatidylcholine (16:0/18:1), which has been identifi ed as a potent endogenous PPAR  ligand, is in-
creased in the serum and liver of CONV-R mice. Increased activation of PPAR  may promote increased lipid 
clearance by inducing expression of LPL. 
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major component of biological membranes. They provide a 
structural framework, maintain membrane permeability 
and also play a role in membrane-mediated cell signaling 
( 44 ). Circulating phosphatidylcholines are incorporated 
into lipoprotein particles ( 45 ) and are a major source of 
choline in the body. Phosphatidylcholines can either be de-
rived from the diet or from de novo synthesis in the liver 
( 45 ), but it is not clear whether the gut microbiota increases 
intestinal absorption and/or hepatic biosynthesis. 
 Of particular interest, we found increased levels of phos-
phatidylcholine (34:1, identifi ed as 16:0/18:1 by tandem 
MS, as shown in supplementary  Fig. III ) in both serum and 
liver tissue of CONV-R mice. This species is a common 
phosphatidylcholine in the liver and comprises approxi-
mately 11% of the nuclear phosphatidylcholines ( 46 ). A 
recent study showed that phosphatidylcholine (16:0/18:1) 
is a physiologic agonist of the nuclear receptor peroxi-
some proliferator-activated receptor (PPAR)  ( 46 ), which 
promotes fatty acid oxidation, lipid transport, ketogenesis, 
and gluconeogenesis, and induces expression of LPL ( 47 ). 
Here, we propose that the microbiota-induced increases 
in phosphatidylcholine (16:0/18:1) observed in serum 
and liver may potentially play a role in increased triglycer-
ide clearance in CONV-R mice through increased PPAR  -
mediated activation of LPL. 
 CONV-R mice die less rapidly in response to starvation 
compared with their GF counterparts, despite losing 
weight at approximately the same rate ( 48 ). One possible 
explanation is that the gut microbiota is essential to pro-
mote PPAR  -regulated increases in hepatic production of 
ketone bodies in the fasting state ( 49 ). Although it remains 
to be shown if this response is mediated by phosphatidyl-
choline (16:0/18:1), it further demonstrates the intricate 
role of the gut microbiota in modulating energy 
metabolism. 
 A large-scale metabolomic study in a birth cohort of 
8,026 children at genetic risk of type 1 diabetes (T1D) 
showed that cord serum as well as prospective serum meta-
bolic profi les of children who later progressed to T1D 
were characterized by low levels of phosphatidylcholines 
and tricarboxylic acid cycle metabolites ( 50 ). The observed 
profi les in T1D progressors are thus similar to those of GF 
mice in the present study. It would therefore be of interest 
to analyze the gut microbiota in the children who progress 
to T1D to determine if this can identify any defi ciency or 
impaired function that predisposes them to the disease. 
 The gut microbiota has coevolved with its host and pro-
vides the host with traits that we did not have to evolve on 
our own. Here, we demonstrate that the gut microbiota 
increases energy metabolism and has systemic effects on 
host lipid metabolism, especially triglycerides and phos-
phatidylcholines ( Fig. 7 ). Thus, the gut microbiota affects 
both energy storing and signaling lipids, reinforcing its 
role as an important environmental factor that regulates 
host metabolism and promotes obesity and diabetes.  
 We thank Carina Arvidsson and Caroline Wennberg for superb 
mouse husbandry, Anna Hallén for help with producing Fig. 7, 
and Jeffrey Gordon for helpful suggestions.  
affected the subcellular compartmentalization of triglycer-
ides, a previous study suggested that increased triglycer-
ides accumulate lipid droplets ( 16 ). 
 Conventionalization of GF mice with a normal microbi-
ota for 14 days resulted in a shift in the levels of serum 
triglyceride species similar to that observed in CONV-R 
mice but did not alter the serum levels of cholesteryl es-
ters, sphingomyelins, and phosphatidylcholines compared 
with GF mice. Although the mechanism at present is un-
clear, the shift in triglycerides tended to be more dramatic 
in CONV-D mice. In contrast, a 14-day colonization did 
not alter triglyceride in the liver as dramatically. Thus, se-
rum and liver display different kinetics in response to con-
ventionalization. We have previously shown that mice that 
have been conventionalized for 14 days have the same mi-
crobial composition as the inoculating microbiota ( 16 ), 
and it is thus unlikely that the lack of effect on lipids other 
than triglycerides was caused by incomplete colonization. 
Although further work is required to determine the impli-
cation of this result, it is possible that the gut microbiota 
has a more immediate effect on molecules involved in en-
ergy storage than on structural and signaling molecules. 
 We showed that the presence of a gut microbiota reduced 
serum levels of chylomicrons but not VLDL-triglycerides 
after a 4 h fast. We then investigated if the reduction in 
chylomicrons resulted from decreased lipid absorption 
from the gut and/or increased lipid clearance. Because it 
is known that the gut microbiota promotes deconjugation 
of bile acids in the intestine ( 41 ), resulting in less effi cient 
emulsifi cation of dietary lipids ( 42 ), we expected to ob-
serve reduced triglyceride absorption from the gut. Sur-
prisingly, we did not observe signifi cant differences in 
triglyceride absorption between CONV-R and GF mice af-
ter administration of a triglyceride bolus. However, we did 
see differences in some phosphatidylcholines and sphin-
gomyelins. It should be noted that the gut microbiota is 
known to increase gastrointestinal motility ( 43 ), which po-
tentially could mask decreased absorptive capacity in 
CONV-R mice. 
 Although serum triglyceride levels were not affected by 
the presence of the gut microbiota 4 h after a lipid bolus, 
the serum chylomicron levels were reduced, consistent 
with increased lipid clearance. Indeed, we have earlier 
shown that conventionalization of GF mice suppresses an 
inhibitor of LPL ( 16 ). Increased activation of LPL will pro-
mote increased lipid clearance, resulting in reduced se-
rum triglyceride levels together with increased storage of 
lipids in adipose tissue and the liver, as observed in the 
CONV-R mice in our study. Furthermore, we also showed 
that the VLDL production rate increased in CONV-R mice. 
Increased VLDL production may explain why we did not 
observe altered VLDL-triglyceride levels in CONV-R mice 
despite increased lipid clearance. 
 We also observed that the gut microbiota has a major in-
fl uence on phosphatidylcholine species, with increases in 
the levels of 16 species in serum and 4 shorter chain species 
in the liver, and decreases in 1 species in adipose tissue and 
4 longer chain species in liver from CONV-R mice compared 
with GF mice after a 4 h fast. Phosphatidylcholines are a 
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